AGEN1571 is a novel high-affinity ILT2 antagonist antibody that promotes adaptive and innate immune responses
Olga Udartseva, Malgorzata Pupecka-Swider,Pilar Garcia-Broncano, Naxin Guo, Spencer Campbell, Elizabeth Klakus,Rebecca Ward, Priyadarshini Iyer, Christine Brittsan, Beth Wensley,Benjamin Morin, Andrew Slee,Dhan Chand,Claire Galand,Olga Ignatovich,Emmanuel Briend,David Savitsky CANCER RESEARCH（2022）
AI 理解论文
溯源树
样例
